This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Jimin Lee: Innovator in Cancer Treatment
Introduction
Jimin Lee is a prominent inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of cancer research through his innovative work. His dedication to developing effective treatments showcases his commitment to improving healthcare outcomes.
Latest Patents
Jimin Lee holds a patent for an agent aimed at the prevention and treatment of cancer. This agent comprises an oxadiazole urea compound that obstructs the activity of STAT3. The patent details how this compound effectively inhibits the growth of cancer cell lines, making it a promising candidate for cancer therapy.
Career Highlights
Jimin Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on groundbreaking research in cancer treatment. His innovative approach has garnered attention in the scientific community.
Collaborations
Jimin Lee has collaborated with notable colleagues, including Byoung-Mog Kwon and Dong Cho Han. Their combined expertise enhances the research efforts in developing effective cancer treatments.
Conclusion
Jimin Lee's contributions to cancer research through his innovative patent highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile